|
|
||||||||
overexpression and activation on pancreatic islet gene expression profile analyzed with oligonucleotide microarrays
1Henry Wellcome Signalling Laboratories and Department of Biochemistry, School of Medical Sciences, University of Bristol, Bristol, BS8 1TD United Kingdom; and 2GlaxoSmithKline, Department of Metabolic Diseases, Research Triangle Park, North Carolina 27709
Submitted 9 January 2004 ; accepted in final form 26 April 2004
Peroxisome proliferator-activated receptor-
(PPAR
) serves as a target for the thiazolidinedione class of antidiabetic drugs and is an important regulator of adipose tissue differentiation. By contrast, the principal target genes for PPAR
in the pancreatic islet and the impact of their induction on insulin secretion are largely undefined. Here, we show that mRNAs encoding both isoforms of rodent PPAR
,
1 and
2, are expressed in primary rat islets and are upregulated by overexpresssion of the lipogenic transcription factor sterol response element-binding protein 1c. Unexpectedly, however, oligonucleotide microarray analysis demonstrates that graded activation of PPAR
achieved with 1) the thiazolidinedione GW-347845, 2) transduction with adenoviral PPAR
1, or 3) a combination of both treatments progressively enhances the expression of genes involved in fatty acid oxidation and transport. Moreover, maximal activation of PPAR
1 reduces islet triglyceride levels and enhances the oxidation of exogenous palmitate while decreasing glucose oxidation, cellular ATP content, and glucose-, but not depolarization-stimulated, insulin secretion. We conclude that, in the context of the pancreatic islet, the principal response to PPAR
expression and activation is the activation of genes involved in the disposal, rather than the synthesis, of fatty acids. Although fatty acid oxidation may have beneficial effects on
-cell function in the longer term by countering
-cell "lipotoxicity," the acute response to this metabolic shift is a marked inhibition of insulin secretion.
-cell; insulin; secretion; peroxisome proliferator-activated receptor-
; sterol regulatory element-binding protein-1c; thiazolidinedione; glucolipotoxicity
This article has been cited by other articles:
![]() |
S. C. Martinez, K. Tanabe, C. Cras-Meneur, N. A. Abumrad, E. Bernal-Mizrachi, and M. A. Permutt Inhibition of Foxo1 Protects Pancreatic Islet {beta}-Cells Against Fatty Acid and Endoplasmic Reticulum Stress-Induced Apoptosis Diabetes, April 1, 2008; 57(4): 846 - 859. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. A. Moibi, D. Gupta, T. L. Jetton, M. Peshavaria, R. Desai, and J. L. Leahy Peroxisome Proliferator-Activated Receptor-{gamma} Regulates Expression of PDX-1 and NKX6.1 in INS-1 Cells Diabetes, January 1, 2007; 56(1): 88 - 95. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Parton, P. J. McMillen, Y. Shen, E. Docherty, E. Sharpe, F. Diraison, C. P. Briscoe, and G. A. Rutter Limited role for SREBP-1c in defective glucose-induced insulin secretion from Zucker diabetic fatty rat islets: a functional and gene profiling analysis Am J Physiol Endocrinol Metab, November 1, 2006; 291(5): E982 - E994. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. G. Lemay and D. H. Hwang Genome-wide identification of peroxisome proliferator response elements using integrated computational genomics J. Lipid Res., July 1, 2006; 47(7): 1583 - 1587. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Tsuboi, M. A. Ravier, L. E. Parton, and G. A. Rutter Sustained Exposure to High Glucose Concentrations Modifies Glucose Signaling and the Mechanics of Secretory Vesicle Fusion in Primary Rat Pancreatic {beta}-Cells. Diabetes, April 1, 2006; 55(4): 1057 - 1065. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hong, L. Chen, P. B. Jeppesen, I. Nordentoft, and K. Hermansen Stevioside counteracts the {alpha}-cell hypersecretion caused by long-term palmitate exposure Am J Physiol Endocrinol Metab, March 1, 2006; 290(3): E416 - E422. [Abstract] [Full Text] [PDF] |
||||
![]() |
S K Richards, L E Parton, I Leclerc, G A Rutter, and R M Smith Over-expression of AMP-activated protein kinase impairs pancreatic {beta}-cell function in vivo J. Endocrinol., November 1, 2005; 187(2): 225 - 235. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |